[go: up one dir, main page]

MX2022005049A - Aerosol-generating element for use in an aerosol-generating article or system. - Google Patents

Aerosol-generating element for use in an aerosol-generating article or system.

Info

Publication number
MX2022005049A
MX2022005049A MX2022005049A MX2022005049A MX2022005049A MX 2022005049 A MX2022005049 A MX 2022005049A MX 2022005049 A MX2022005049 A MX 2022005049A MX 2022005049 A MX2022005049 A MX 2022005049A MX 2022005049 A MX2022005049 A MX 2022005049A
Authority
MX
Mexico
Prior art keywords
aerosol
aerosol generating
matrix structure
solid continuous
continuous matrix
Prior art date
Application number
MX2022005049A
Other languages
Spanish (es)
Inventor
Ping Li
Laurent Lavanant
Gisèle Ongmayeb
Original Assignee
Philip Morris Products Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philip Morris Products Sa filed Critical Philip Morris Products Sa
Publication of MX2022005049A publication Critical patent/MX2022005049A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
    • A24B15/283—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed by encapsulation of the chemical substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
    • A24B15/303—Plant extracts other than tobacco
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
    • A24D1/00—Cigars; Cigarettes
    • A24D1/20—Cigarettes specially adapted for simulated smoking devices
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/40—Constructional details, e.g. connection of cartridges and battery parts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Manufacture Of Tobacco Products (AREA)

Abstract

Se proporciona un elemento generador de aerosol para su uso en un artículo o sistema generador de aerosol. El elemento generador de aerosol comprende: una estructura de matriz continua sólida; y una formulación generadora de aerosol dispersada dentro de la estructura de matriz continua sólida. La formulación generadora de aerosol está atrapada dentro de la estructura de matriz continua sólida y puede liberarse de la estructura de matriz continua sólida tras el calentamiento del elemento generador de aerosol. La estructura de matriz continua sólida es una matriz polimérica que comprende uno o más polímeros formadores de matriz, y la formulación generadora de aerosol dispersada dentro de la estructura de matriz continua sólida comprende al menos un compuesto alcaloide o cannabinoide y al menos 30 por ciento en peso de un alcohol polihídrico.An aerosol generating element is provided for use in an aerosol generating article or system. The aerosol generating element comprises: a solid continuous matrix structure; and an aerosol generating formulation dispersed within the solid continuous matrix structure. The aerosol generating formulation is trapped within the solid continuous matrix structure and can be released from the solid continuous matrix structure upon heating of the aerosol generating element. The solid continuous matrix structure is a polymer matrix comprising one or more matrix-forming polymers, and the aerosol-generating formulation dispersed within the solid continuous matrix structure comprises at least one alkaloid or cannabinoid compound and at least 30 percent in weight of a polyhydric alcohol.

MX2022005049A 2019-11-04 2020-10-29 Aerosol-generating element for use in an aerosol-generating article or system. MX2022005049A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19206993 2019-11-04
PCT/EP2020/080456 WO2021089413A1 (en) 2019-11-04 2020-10-29 Aerosol-generating element for use in an aerosol-generating article or system

Publications (1)

Publication Number Publication Date
MX2022005049A true MX2022005049A (en) 2022-05-16

Family

ID=68426352

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022005049A MX2022005049A (en) 2019-11-04 2020-10-29 Aerosol-generating element for use in an aerosol-generating article or system.

Country Status (13)

Country Link
US (1) US20220361557A1 (en)
EP (1) EP4054354A1 (en)
JP (1) JP2022554341A (en)
KR (1) KR20220093166A (en)
CN (1) CN115038346A (en)
AU (1) AU2020381237B2 (en)
BR (1) BR112022008248A2 (en)
CA (1) CA3156389A1 (en)
IL (1) IL292538B1 (en)
MX (1) MX2022005049A (en)
PH (1) PH12022550653A1 (en)
WO (1) WO2021089413A1 (en)
ZA (1) ZA202206046B (en)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240016A (en) * 1991-04-19 1993-08-31 Philip Morris Incorporated Thermally releasable gel-based flavor source for smoking articles
US20070000505A1 (en) * 2005-02-24 2007-01-04 Philip Morris Usa Inc. Smoking article with tobacco beads
EP2361516A1 (en) 2010-02-19 2011-08-31 Philip Morris Products S.A. Aerosol-generating substrate for smoking articles
JP6017546B2 (en) 2011-05-31 2016-11-02 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム Rod used for smoking articles
JP6062437B2 (en) * 2011-09-09 2017-01-18 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム Smoking articles containing flavor delivery materials
CN109195462B (en) * 2016-05-31 2022-02-25 菲利普莫里斯生产公司 Heat diffuser for an aerosol-generating system
JP2019526233A (en) 2016-07-29 2019-09-19 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム Aerosol generation system with heated gel container
EP3490392B1 (en) * 2016-07-29 2022-11-23 Philip Morris Products S.A. Aerosol-generating system comprising a gel containing cartridge and a device for heating the cartridge
US11785677B2 (en) * 2017-06-08 2023-10-10 Altria Client Services Llc Cartridge having a susceptor material
GB201718032D0 (en) * 2017-11-01 2017-12-13 British American Tobacco Investments Ltd Aerosolisable gel
GB201718031D0 (en) * 2017-11-01 2017-12-13 British American Tobacco Investments Ltd Aerosolisable gel
CN111867405B (en) * 2018-04-06 2023-04-04 菲利普莫里斯生产公司 Nicotine gel
JP6603817B1 (en) * 2019-01-18 2019-11-06 三生医薬株式会社 Seamless capsule and filter and smoking device including the same

Also Published As

Publication number Publication date
KR20220093166A (en) 2022-07-05
AU2020381237A1 (en) 2022-03-03
PH12022550653A1 (en) 2023-04-03
CA3156389A1 (en) 2021-05-14
AU2020381237B2 (en) 2025-12-18
JP2022554341A (en) 2022-12-28
ZA202206046B (en) 2024-08-28
WO2021089413A1 (en) 2021-05-14
US20220361557A1 (en) 2022-11-17
IL292538A (en) 2022-06-01
CN115038346A (en) 2022-09-09
EP4054354A1 (en) 2022-09-14
IL292538B1 (en) 2026-02-01
BR112022008248A2 (en) 2022-07-12

Similar Documents

Publication Publication Date Title
MX2022005047A (en) AEROSOL GENERATING ELEMENT MODIFIED FOR USE IN AN AEROSOL GENERATING ARTICLE OR SYSTEM.
CL2008001951A1 (en) Substituted imidazo [1,2-a] pyrimidin-2-ylmethyl derived compounds; pharmaceutical composition comprising said compound; and use of the compound for sleep disorder, depression, anxiety, substance abuse-related disorder, among others.
UY30846A1 (en) OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES
CL2011000527A1 (en) Compounds derived from benzofuran; pharmaceutical composition that includes them; and their use in the treatment of hepatitis c.
DOP2009000165A (en) DERIVATIVES OF REPLACED OXINDOL, MEDICATIONS THAT UNDERSTAND AND USE THEMSELVES
AR100297A1 (en) A SUPPORT AGENT
CL2011000301A1 (en) Compounds derived from purine with immunomodulatory activity; pharmaceutical composition comprising them; and use of them in the treatment of allergic diseases, allergic rhinitis, asthma, infectious diseases and cancer.
CL2008003576A1 (en) 6,7-dihydro-5h-imidazo [1,2-alpha] imidazole-3-carboxylic acid amide derivative compounds; pharmaceutical composition comprising them; and uses in the treatment of an inflammatory condition.
UY35298A (en) FORMULATION IN SOLID DISPERSION OF AN ANTIVIRAL COMPOUND
AR099572A1 (en) ARTICLES FOR SMOKING WITH RELEASE OF A LIQUID COMPONENT THAT HAS A FRAGILE COATING
CL2009000541A1 (en) Use of an activatable matrix degrading enzyme (amde) for the formulation of a drug for sub-epidermal administration; pharmacological composition and its use; combination comprising amde, an activator and an agent; container for amde and activator; kit comprising said container
CL2007002635A1 (en) Quinazolinone and isoquinolinone derived compounds, modulators of hpa axis activity; pharmaceutical composition comprising them; and its use in the treatment and / or prevention related to stress or depression.
BR112022010450A2 (en) AEROSOL GENERATING MATERIAL COMPRISING AN AMORPHOUS SOLID, SUBSTRATE, ARTICLE FOR USE WITH A NON-FUEL AEROSOL DELIVERY DEVICE, NON-FUEL AEROSOL DELIVERY SYSTEM, METHOD, METHOD FOR GENERATING AN AEROSOL USING A NON-FUEL AEROSOL DELIVERY SYSTEM AND USE
AR059320A1 (en) ANTITUMORIAL COMPOSITION THAT INCLUDES AN INHIBITOR OF CYCLINE DEPENDENT KINASES AND AN ANTIBODY THAT INHIBITS A GROWTH FACTOR AND / OR AN ANTIMITOTIC COMPOUND
AR050621A1 (en) TRANSDERMAL THERAPEUTIC SYSTEM WITH AN ADHERENT COAT PROCEDURE FOR SILICONING A BACK COAT AND EMPLOYMENT OF THE BACK COAT
BR112018003129A2 (en) resins for use as a bonding layer in multilayer structures and multilayer structures comprising the same
BR112017013035A2 (en) surface protection film
CL2008003799A1 (en) Pharmaceutical composition comprising raloxifene in immediate release tablet form; Useful for the treatment and / or prevention of osteoporosis.
CL2015002113A1 (en) Azetidinloxyphenylpyrrolidine compounds
DOP2010000197A (en) OXINDOL DERIVATIVES SUBSTITUTED AND USE OF THE SAME FOR THE TREATMENT OF VASOPRESINE DEPENDENT DISEASES
CL2009000599A1 (en) Compounds derived from substituted 4,5-dihydro-1h-pyrazol (4,3-g) benzothiazole; pharmaceutical composition; Useful for the treatment and prevention of cancer, infections, inflammatory and autoimmune diseases, among others.
CO6551744A2 (en) COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY
MX2022005049A (en) Aerosol-generating element for use in an aerosol-generating article or system.
AR069639A1 (en) COMPOSITION OF NANOPARTICLES WITH MODIFIED SURFACE
BR112017009576A2 (en) binder composition and paint formulation produced thereof